{
  "id": "regimen-optimization",
  "type": "regimen_analysis",
  "display_name": "Regimen Optimization",
  "description": "Analysis of treatment regimens for outcomes and cost optimization",
  "patient_count": 1850,
  "summary": "Three priority areas identified for regimen optimization, with potential for 12% cost reduction while maintaining or improving outcomes.",
  "created_date": "2023-04-12",
  "charts": [
    {
      "title": "Regimen Cost-Effectiveness by Cancer Type",
      "chart_type": "scatter",
      "data_source": "regimen-optimization-details.json"
    }
  ],
  "recommendations": [
    "Standardize first-line NSCLC treatment selection based on biomarker status",
    "Implement dose optimization protocol for targeted therapies",
    "Develop pathway compliance monitoring system"
  ]
} 